In the last decade, researchers have uncovered the source of one of the important mutations is called as Kirsten rat sarcoma oncogene (KRAS) mutations in lung cancers using molecular studies (Gautschi et al., 2007). The gene discussed is KRAS; the disease is lung carcinoma.